Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Certara stock

CERT
US15687V1098
A2QJL8

Price

9.95
Today +/-
-0.03
Today %
-0.36 %
P

Certara stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Certara stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Certara stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Certara stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Certara's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Certara Stock Price History

DateCertara Price
11/19/20249.95 undefined
11/18/20249.99 undefined
11/15/20249.96 undefined
11/14/202410.53 undefined
11/13/202410.78 undefined
11/12/202410.60 undefined
11/11/202410.89 undefined
11/8/202411.03 undefined
11/7/202410.99 undefined
11/6/202410.91 undefined
11/5/202410.31 undefined
11/4/202410.25 undefined
11/1/202410.25 undefined
10/31/202410.20 undefined
10/30/202410.31 undefined
10/29/202410.35 undefined
10/28/202410.42 undefined
10/25/202410.20 undefined
10/24/202410.12 undefined
10/23/202410.54 undefined
10/22/202411.23 undefined
10/21/202411.20 undefined

Certara Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Certara, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Certara from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Certara’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Certara. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Certara’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Certara’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Certara’s growth potential.

Certara Revenue, EBIT and net profit per share

DateCertara RevenueCertara EBITCertara Net Income
2028e591.27 M undefined180.66 M undefined116.57 M undefined
2027e492.05 M undefined160.77 M undefined95.23 M undefined
2026e479.2 M undefined141.82 M undefined94.86 M undefined
2025e432.51 M undefined129.33 M undefined82 M undefined
2024e391.17 M undefined112.19 M undefined68.14 M undefined
2023354.34 M undefined6.21 M undefined-55.36 M undefined
2022335.6 M undefined33.2 M undefined14.7 M undefined
2021286.1 M undefined13.7 M undefined-13.3 M undefined
2020243.5 M undefined-21.8 M undefined-49.4 M undefined
2019208.5 M undefined19.6 M undefined-8.9 M undefined
2018163.7 M undefined-4.7 M undefined-33.3 M undefined

Certara Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2018201920202021202220232024e2025e2026e2027e2028e
163208243286335354391432479492591
-27.6116.8317.7017.135.6710.4510.4910.882.7120.12
56.4461.5458.4460.8460.6060.1754.4849.3144.4743.2936.04
9212814217420321300000
-33-8-49-1314-5568829495116
--75.76512.50-73.47-207.69-492.86-223.6420.5914.631.0622.11
152.7152.7133.2149.8159.4158.9400000
-----------
Details

Keystats

ⓘ

Revenue and Growth

The Certara Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Certara is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
201820192020202120222023
           
11.729.3271.4185.8236.6234.95
46.349.354.16982.384.5
3.63.110.79.36.58.75
000000
7.35.910.410.716.911.99
68.987.6346.6274.8342.3340.2
5.44.63.915.616.812.27
1.31.11.2000
000000
459.6428396.4511.8486.8487.04
514.3515518.6703.4717.7716.33
20.82.76.29.37.29
0.980.950.921.241.231.22
1.051.041.271.511.571.56
           
1.31.31.51.61.61.6
0.510.510.881.121.151.18
-14.4-12.9-62.3-75.6-60.9-116.23
-1.6-5.5-1.6-3.9-8.2-7.59
000000
0.490.490.821.041.081.06
4.94.96.47.57.55.17
18.9262932.538.141.73
38.327.9354954.480.1
000000
3.44.353.333.02
65.563.175.492.3103130.02
404.8397.1294.4291.7290288.22
85.782.275.976.16550.83
2.82.71.69.835.147.23
493.3482371.9377.6390.1386.28
558.8545.1447.3469.9493.1516.3
1.051.041.271.511.581.57
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Certara provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Certara's financial health and stability.

Assets

Certara's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Certara must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Certara after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Certara's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201820192020202120222023
-33-8-49-1314-55
374142455256
-3-6-7-1-11-16
88-6-23-4
451306263131
252627141719
341281019
113844609282
-11-9-7-8-12-15
-73-9-8-269-27-79
-6200-261-15-64
000000
58-8-104-3-3-3
0031513300
57-8208123-7-9
-1.00--2.00-6.00-4.00-6.00
000000
-617243-8653-4
0.128.5136.8751.4980.0167.43
000000

Certara stock margins

The Certara margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Certara. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Certara.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Certara's sales revenue. A higher gross margin percentage indicates that the Certara retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Certara's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Certara's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Certara's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Certara. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Certara's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Certara Margin History

Certara Gross marginCertara Profit marginCertara EBIT marginCertara Profit margin
2028e60.2 %30.55 %19.72 %
2027e60.2 %32.67 %19.35 %
2026e60.2 %29.6 %19.8 %
2025e60.2 %29.9 %18.96 %
2024e60.2 %28.68 %17.42 %
202360.2 %1.75 %-15.62 %
202260.52 %9.89 %4.38 %
202160.99 %4.79 %-4.65 %
202058.64 %-8.95 %-20.29 %
201961.73 %9.4 %-4.27 %
201856.63 %-2.87 %-20.34 %

Certara Stock Sales Revenue, EBIT, Earnings per Share

The Certara earnings per share therefore indicates how much revenue Certara has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Certara earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Certara's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Certara’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Certara's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Certara Revenue, EBIT and net profit per share

DateCertara Sales per ShareCertara EBIT per shareCertara Earnings per Share
2028e3.67 undefined0 undefined0.72 undefined
2027e3.06 undefined0 undefined0.59 undefined
2026e2.98 undefined0 undefined0.59 undefined
2025e2.69 undefined0 undefined0.51 undefined
2024e2.43 undefined0 undefined0.42 undefined
20232.23 undefined0.04 undefined-0.35 undefined
20222.11 undefined0.21 undefined0.09 undefined
20211.91 undefined0.09 undefined-0.09 undefined
20201.83 undefined-0.16 undefined-0.37 undefined
20191.37 undefined0.13 undefined-0.06 undefined
20181.07 undefined-0.03 undefined-0.22 undefined

Certara business model

Certara Inc. is a company specializing in the development of innovative solutions for the pharmaceutical industry. It offers a wide range of services and products to support its customers in all phases of drug development. The company was formed in 2008 through the merger of Tripos International and Pharsight Corporation. It combines expertise in software development, modeling and simulation, and offers solutions to the pharmaceutical industry's challenges. Certara provides services in modeling and simulation, analysis software development, pharmacokinetics, and regulatory support. Its products include software solutions like Knowledgebase for Clinical Trials, Phoenix modeling software, and Simcyp analysis software. The company also offers training and educational programs to provide customers with necessary knowledge. Certara focuses on integrity, transparency, and scientific approach in its offerings. Certara is one of the most popular companies on Eulerpool.com.

Certara SWOT Analysis

Strengths

Certara Inc has a strong reputation in the pharmaceutical industry due to its advanced technology and expertise in pharmacokinetic modeling and simulation.

The company offers a comprehensive range of software solutions and consulting services, which enables it to provide tailored solutions to pharmaceutical companies.

Certara Inc has a well-established customer base, including top pharmaceutical companies and regulatory agencies, which provides a stable source of revenue.

Weaknesses

Certara Inc relies heavily on the pharmaceutical industry, which is subject to market fluctuations and regulatory changes. These factors can impact the company's financial performance.

The company faces intense competition from other technology and consulting firms in the pharmaceutical industry, which could potentially affect its market share.

Opportunities

As pharmaceutical companies continue to focus on drug development and regulatory approval, there is an increasing demand for Certara's services and software solutions.

The incorporation of artificial intelligence and machine learning in pharmacokinetic modeling presents an opportunity for Certara Inc to further enhance its offerings and gain a competitive edge.

Threats

Changes in government regulations and industry standards can pose a threat to Certara Inc's business operations and may require the company to adapt its services accordingly.

The emergence of new competitors in the pharmaceutical technology and consulting space could potentially erode Certara Inc's market share and impact its revenue growth.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Certara Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Certara historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Certara shares outstanding

The number of shares was Certara in 2023 — This indicates how many shares 158.936 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Certara earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Certara's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Certara’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Certara's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Certara.

Certara latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.11 0.13  (15.86 %)2024 Q3
6/30/20240.11 0.07  (-33.59 %)2024 Q2
3/31/20240.1 0.1  (-0.99 %)2024 Q1
12/31/20230.11 0.09  (-19.06 %)2023 Q4
9/30/20230.11 0.11  (-1.08 %)2023 Q3
6/30/20230.13 0.12  (-6.4 %)2023 Q2
3/31/20230.12 0.12  (-2.76 %)2023 Q1
12/31/20220.13 0.16  (20.85 %)2022 Q4
9/30/20220.1 0.1  (-3.47 %)2022 Q3
6/30/20220.11 0.09  (-19.79 %)2022 Q2
1
2

Eulerpool ESG Scorecard© for the Certara stock

Eulerpool World ESG Rating (EESG©)

46/ 100

🌱 Environment

24

👫 Social

71

🏛️ Governance

44

Environment

Scope 1 - Direct Emissions
441.77
Scope 2 - Indirect emissions from purchased energy
667.41
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
1,109.19
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Certara shareholders

%
Name
Stocks
Change
Date
22.57926 % Arsenal Capital Management LP36,345,83503/28/2024
7.74998 % The Vanguard Group, Inc.12,475,137-56,3486/30/2024
7.73797 % BlackRock Institutional Trust Company, N.A.12,455,816-516,8966/30/2024
5.97340 % Mubadala Investment Company PJSC9,615,38406/30/2024
4.57530 % Wasatch Global Investors Inc7,364,8652,440,0206/30/2024
3.39990 % Geneva Capital Management LLC5,472,8171,068,6186/30/2024
3.24091 % William Blair Investment Management, LLC5,216,888-502,9026/30/2024
2.53923 % ClearBridge Investments, LLC4,087,397-85,7986/30/2024
2.33541 % JP Morgan Asset Management3,759,315-304,1446/30/2024
2.20991 % State Street Global Advisors (US)3,557,288-3536/30/2024
1
2
3
4
5
...
10

Certara Executives and Management Board

Dr. William Feehery(53)
Certara Chief Executive Officer, Director (since 2019)
Compensation 6.23 M
Mr. M. Andrew Schemick(49)
Certara Senior Vice President - Corporate Operations and Integration
Compensation 2.39 M
Mr. Leif Pedersen(59)
Certara President - Software
Compensation 1.78 M
Dr. Patrick Smith(53)
Certara President - Integrated Drug Development
Compensation 1.78 M
Dr. Robert Aspbury(51)
Certara President - Simcyp
Compensation 1.67 M
1
2
3
4

Most common questions regarding Certara

What values and corporate philosophy does Certara represent?

Certara Inc represents a strong commitment to scientific excellence and innovation, striving to bridge the gap between discovery and application. The company values collaborative partnerships, with a focus on providing cutting-edge solutions to support informed decision-making in drug development and regulatory processes. Certara fosters a culture of integrity and transparency, aiming to deliver value to its clients and stakeholders while improving patient outcomes. With its advanced technology platforms and expert-driven approaches, Certara empowers researchers and drug developers to optimize drug discovery and development, ensuring safer and more effective therapies for patients worldwide.

In which countries and regions is Certara primarily present?

Certara Inc is primarily present in multiple countries and regions around the world. With a global presence, the company operates in North America, Europe, Asia-Pacific, and Latin America. It has established offices and collaborations in various key pharmaceutical and biotechnology hubs, including the United States, United Kingdom, Germany, France, Japan, China, and Brazil. Certara's extensive international reach allows it to serve a diverse clientele and partner with industry leaders across different geographical locations, further strengthening its position as a leading provider of scientific software and services in the life sciences industry.

What significant milestones has the company Certara achieved?

Certara Inc has achieved several significant milestones throughout its history. Some noteworthy achievements include the acquisition of Simcyp Limited, a leading provider of physiologically-based pharmacokinetic modeling and simulation services. This acquisition has strengthened Certara's position as a global leader in modeling and simulation software and has expanded its reach in the pharmaceutical industry. Additionally, Certara has collaborated with key industry stakeholders to develop innovative solutions for drug development and optimization, further contributing to its reputation as a trusted partner in pharmaceutical sciences. The company's commitment to research, technological advancements, and strategic partnerships has propelled Certara Inc towards continuous growth and success.

What is the history and background of the company Certara?

Certara Inc is a leading provider of model-informed drug development and regulatory science solutions. Founded in 2008, Certara has constantly evolved and grown, becoming a trusted partner to more than 1,500 biopharmaceutical companies and academic institutions. Certara's innovative software and services help improve the efficiency and success of drug development, reducing costs and timeframes. With a team of highly experienced scientists and industry experts, Certara combines cutting-edge technology with deep domain knowledge to facilitate informed decision-making throughout the drug development process. Certara's commitment to excellence has enabled it to establish a strong presence globally, making it a highly respected and influential player in the pharmaceutical industry.

Who are the main competitors of Certara in the market?

The main competitors of Certara Inc in the market include industry leaders such as Simulations Plus, Inc. and Schrödinger, Inc.

In which industries is Certara primarily active?

Certara Inc is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of Certara?

Certara Inc operates with a business model focused on providing solutions and services to support the entire drug development process. As a leading provider of biosimulation software and technology, Certara integrates quantitative methods and software applications to help pharmaceutical and biotechnology companies optimize development and improve drug safety. With a strong focus on precision medicine and personalized therapies, Certara combines scientific expertise with advanced technology to facilitate decision-making in clinical and regulatory activities. Their comprehensive suite of tools and services enables clients to streamline drug development, predict drug outcomes, and ultimately bring safer and more effective medicines to market efficiently.

What is the P/E ratio of Certara 2024?

The Certara P/E ratio is 23.22.

What is the P/S ratio of Certara 2024?

The Certara P/S ratio is 4.04.

What is the Quality Investing of Certara?

The Quality Investing for Certara is 2/10.

What is the revenue of Certara 2024?

The expected Certara revenue is 391.17 M USD.

How high is the profit of Certara 2024?

The expected Certara profit is 68.14 M USD.

What is the business model of Certara

Certara Inc is a leading company in the field of biosimulation and technology platforms for drug development. The company offers a wide range of products and services to support its customers in developing, testing, and bringing safer and more effective drugs to market. Certara's business model includes three main divisions: Modelling & Simulation, Regulatory Science, and Clinical Pharmacology. Each of these divisions offers specialized services and products to meet the needs of different customers in the healthcare industry. Modelling & Simulation is an important division of Certara, based on the application of biosimulation and modeling techniques to support drug research and development activities. This division specializes in providing knowledge in modeling and simulation methods and developing software products to help evaluate and optimize the effectiveness and safety of drugs. The Regulatory Science division is focused on promoting collaborations with regulatory authorities in the evaluation of drug products. This division works with pharmaceutical companies and authorities to ensure that drug products meet all necessary regulatory requirements and that their safety and efficacy are ensured during clinical trials and use. Certara's Clinical Pharmacology division specializes in developing strategies to optimize the clinical effectiveness of drugs through clinical pharmacology and bioanalysis phases. Additionally, this division also develops behavioral diagnostic tools and innovative technologies to optimize drug selection and patient treatment. Certara also offers a variety of products tailored to customer needs, including simulation tools, analysis tools, databases, and software packages for drug development. Some of the most commonly used products are the D360 platform and the physiology platform (PK/PD modeling), which specifically focus on analyzing and modeling drug effects in the body. Overall, Certara's business model is designed to offer customers a comprehensive range of services and products to support drug development. By combining modeling and simulation strategies, regulatory science methods, and clinical pharmacology, the company provides its customers with a unique solution for optimizing drug development. With its portfolio of innovative products and services, Certara is a leader in the industry and sets the standard for the future of drug development.

What is the Certara dividend?

Certara pays a dividend of 0 USD distributed over payouts per year.

How often does Certara pay dividends?

The dividend cannot currently be calculated for Certara or the company does not pay out a dividend.

What is the Certara ISIN?

The ISIN of Certara is US15687V1098.

What is the Certara WKN?

The WKN of Certara is A2QJL8.

What is the Certara ticker?

The ticker of Certara is CERT.

How much dividend does Certara pay?

Over the past 12 months, Certara paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Certara is expected to pay a dividend of 0 USD.

What is the dividend yield of Certara?

The current dividend yield of Certara is .

When does Certara pay dividends?

Certara pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Certara?

Certara paid dividends every year for the past 0 years.

What is the dividend of Certara?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Certara located?

Certara is assigned to the 'Health' sector.

Wann musste ich die Aktien von Certara kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Certara from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Certara pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Certara in the year 2023?

In the year 2023, Certara distributed 0 USD as dividends.

In which currency does Certara pay out the dividend?

The dividends of Certara are distributed in USD.

All fundamentals about Certara

Our stock analysis for Certara Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Certara Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.